The oncology precision medicine market is anticipated to expand from $78.9 billion in 2023 to $165.2
The Oncology Precision Medicine Market encompasses the development and application of tailored therapeutic strategies based on the genetic, environmental, and lifestyle factors of individual cancer patients. This sector integrates genomic testing, advanced diagnostics, and targeted therapies to enhance treatment efficacy and patient outcomes. It includes pharmaceuticals, diagnostic tools, and services that emphasize personalized care, driving innovations in cancer treatment and fostering a more effective, patient-centric approach to oncology.